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1. Introduction 
Bacteria are surrounded by a rigid cell wall, which gives them their shape and protects 
them from rupture due to osmotic pressure. An important component of the cell wall is 
peptidoglycan (PG), a net-like structure consisting of strands of alternating 
N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNac) molecules connected by 
short peptide chains (Figure 1).  
 
Figure 1: Peptidoglycan components of gram-negative bacteria (left) and gram-positive bacteria (right). 
The peptide stem of gram-negative bacteria is directly connected between amino acids at position 3 of one 
chain to position 4 of the other chain. Peptidoglycan of gram-positive bacteria is linked by a pentaglycine. 
 
   Whereas gram-negative bacteria have only few layers of PG and are covered by an outer 
membrane, gram-positive bacteria have a much thicker PG as the outmost layer. The 
connecting peptide stems contain unique D-amino acids, but differ in their sequence 
depending on the species. PG is constantly remodeled during growth and numerous 
hydrolases cleave PG, releasing the fragments to the medium or recover and recycle them. In 
the latter case the di-saccharide blocks with a tetra-peptide stem are imported back to the 
cytoplasm, further degraded and used in the synthesis of new PG (1). One enzyme in this cell 
wall recycling (*) pathway, the cytoplasmic L,D-carboxypeptidase A (LdcA), cleaves the 
terminal D-Ala from the tetra-peptide, which is essential since only the tripeptide can be 
reused. LdcA is the only enzyme for this task. Though there are differences in the recycling 
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process of gram-positive and gram-negative bacteria, LdcA homologs have been found in 
both types (2).  
   In the past antibiotics targeted mainly steps in the synthesis of PG, however due resistance 
towards these kind of antibiotics it is necessary to find new ways to fight bacterial infections. 
Recycling is a common way for bacteria to save resources and as much as 50% of PG are 
recycled in E.coli (3). LdcA is therefore a potential drug target. 
   I determined the structure of LdcA of the gram-negative Escherichia coli (EcLdcA) in the 
native form as well as of an active site mutant to elucidate its mechanism. Further the 
oligomeric form (*) of the enzyme has been confirmed and the structure compared to the 
LdcAs of other species. Though it was not possible to obtain a structure with a bound ligand, 
the findings should help to lead to inhibitors in the cell wall recycling process. 
 
2. Material and Methods 
Expression and purification 
   The ldcA gene from E. coli was amplified by PCR from genomic DNA and inserted into 
pET28b plasmid between the restriction sites Nde I and Bam H1. The resulting plasmid was 
transformed into E. coli BL21 and grown in LB medium with 20 g/ml kanamycin at 37℃ 
with shaking. When the OD600 reached 0.6, expression of the protein was induced by adding 
IPTG to a final concentration of 0.5 mM, and cell culture was continued at 20℃ overnight. 
The cells were collected, re-suspended and lysed by sonication. After centrifugation the 
supernatant was loaded on a nickel NTA agarose column, washed and then eluted with 
250 mM imidazole. The dialyzed and filtered fractions were further purified using a HiTrap Q 
HP column and LdcA eluted at about 150 mM NaCl. Finally the protein was loaded onto a 
Superdex 200 gel filtration column equilibrated with 50 mM Tris-HCl pH 8.5, 50 mM NaCl. 
The main fractions were pooled and concentrated to 11 mg/ml for crystallization. 
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   To introduce a site-directed mutation, appropriate primers were used to change the active 
site serine to alanine (S106A). The PCR product was digested with NdeI and BamH1 at 37℃ 
for 3 hours, purified and then ligated into a cut vector using T4 DNA ligase at 16℃ for 3 
hours. This vector was transformed into E. coli DH5α cells and the plasmid with the mutant 
prepared with Nippon Genetics Miniprep Kit. Expression and purification were done by the 
same protocol as the native LdcA.  
 
Crystallization and data collection 
   Using the hanging drop vapor diffusion method, crystals were grown in 0.02 M Tris-HCl 
pH 8.5, 0.2 M sodium thiocyanate and 12% PEG 3350. The space-group was I222. Data were 
collected at beamline BL17 at Photon Factory, Tsukuba to a resolution of 1.75 Å. Another 
crystallization condition was 85 mM HEPES pH 7.5, 3.655 M NaCl and 15% glycerol. These 
crystals were used for soaking in 10 mM heavy atom compound sodium 
ethylmercurithiosalicylate (EMTS) for 1 hour resulting in a usable derivative. 
Mercury-derivative data sets were collected at beamline BL-5A of the Photon Factory to 
resolution limits of 2.54 Å. Crystals of the LdcA mutant grew in 85 mM HEPES pH 7.5, 
3.655 M NaCl and 15% glycerol, however in another space group P21212. Data were collected 
at beamline BL17 at the Photon Factory, Tsukuba. The maximum resolution was 1.75 Å. 
Structure determination  
   All data were integrated and scaled using the program XDS. Autosol, part of the Phenix 
suite, was used for experimental phase determination of the heavy-atom-soaked crystal data 
and the initial structure was built using Autobuild. This model was manually adjusted with 
COOT and refined with REFMAC. The resulting model was used as a template for molecular 
replacement of the high-resolution data of the native crystal. Model building and refinement 
were performed as described above. The structure of the mutant was determined by molecular 
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replacement using the native data as a template. Table 1 shows data collection and refinement 
statistics for the native and mutant models. 
 
   Table 1: Data collection and structure refinement statistics 
 
Analytical Ultracentrifugation 
   To confirm that LdcA exists as a dimer in solution sedimentation velocity experiments 
were carried out. Sample and reference solution were loaded into a two-channel center-piece 
with sapphire windows. The rotor was kept stationary in the vacuum chamber for 1 hour for 
temperature equilibration. Absorbance scans at 280 nm were taken at 10 min. intervals during 
sedimentation at 30,000 rpm. The scans were analyzed using the continuous distribution 
module of the program SEDFIT. This distribution was converted to molar mass distribution. 
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3. Results 
Crystallization 
   The LdcA protein crystallized under two different conditions and in different space groups. 
Though the original native crystal diffracted to a high resolution under the Tris-condition, 
crystals of the other condition (HEPES) were more robust towards soaking with heavy atoms. 
5 mercury sites could be identified and the experimental phases were determined by SAD. 
The mutated LdcA was also crystallized under the HEPES condition and diffracted well, 
however the space group was an orthorhombic P21212 with 2 molecules in the asymmetric 
unit (ASU), whereas the native crystal was I222 with 1 molecule in the ASU. 
 
Overall structure  
   The EcLdcA structure consists of 8 α-helices and 2 β-sheets. One of the β-sheets is on the 
surface and twisted, the other is between the helices 6 and 7 (Figure 2). Comparing the 
EcLdcA structure to the LdcA of other gram-negative bacteria like Pseudomonas aeruginosa 
(PaLdcA) (4) or Novosphingobium aromaticivorans (NaLdcA) (5) reveals that the structures 
have highly conserved parts, especially around the active site. Since the structures of both 
bacteria lack completeness, the closest related structure was of the self-immunity protein 
MccF, which cleaves the antimicrobial compound microcin C7 (6). Both molecules possess 
the same serine protease and both models align very closely (Figure 3). One difference is an 
extended loop to the active site in MccF of 29 residues, which corresponds to just 3 residues 
in EcLdcA. It might be important for substrate specificity. 
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Figure 2: Ribbon diagram of one subunit of 
EcLdcA with conserved areas in red and the 
catalytic triad as sticks.  
 
Figure 3: Overlay of ribbons of EcLdcA 
(beige) and MccF (blue) subunits 
 
Active Site 
   The active sites of the LdcA structures of all four compared structures are highly 
conserved. All possess the serine protease with the catalytic triad (*) serine, glutamate 
and histidine (S106, E200, H270 in EcLdcA).  
Mutant 
  The mutant with the replacement of the active site serine by an alanine (S106A) was 
created to facilitate binding, but not cleavage of the substrate. However the missing serine 
hydroxyl group might have been responsible that the crystal crystallized under a different 
space group P21212, although the crystallization condition was unchanged. The crystal 
diffracted to a maximum resolution of 1.75 Å and has a dimer in the asymmetric unit. 283 
residues were ordered, however some residues were missing, but are all distant from the 
active site (>10 Å). The mutated active site itself does not show deviations due to the 
mutation. However, Gly75 and Gly76, both highly ordered in the native structure are 
more flexible in the mutant. The residue Ile202 differs considerably from the native 
  
model. In the native LdcA its function is probably to keep His270 of the catalytic triad in 
place. This is not the case in the mutant, which is more flexible around these residues.  
Oligomeric Form 
   The analytical ultracentrifugation experiment clearly showed, that EcLdcA exists as a 
dimer in solution. There was only one clear peak at 69 kDa, indicating the dimer. Also the 
other models show a dimeric structure and all have a conserved arginine residue (Arg211 
in EcLdcA) pointing to the active site of the other subunit chain. Because it is rather close, 
it might have the function to hold or stabilize the substrate. Unfortunately a 
substrate-bound structure could not be obtained for confirmation in EcLdcA. 
   EcLdcA possesses a rather large dimer interface of about 1,700 Å with 48 contact 
points including salt bridges. 
 
4. Discussion 
   The structures of 3 L,D-carboxypeptidases A in gram-negative bacteria revealed 
highly conserved areas especially around the active site. The recycling pathway requires 
tripeptides for re-use in PG synthesis, therefore an L,D-carboxypeptidase is essential to 
cleave the terminal D-Ala after re-import to the cytoplasm. To obtain a substrate-bound 
structure the commercially available pentapeptide was used. Purified DacB, a D-Alanine 
carboxypeptidase, responsible for cleaving the D-Ala on position five of the peptide stem 
at the transpeptidation step was utilized to create the substrate for LdcA, the tetrapeptide. 
However a substrate-bound structure could not be obtained neither by co-crystallization 
nor by soaking of LdcA crystals in the tetrapeptide solution.  
  
   Also in gram-positive bacteria with their much thicker PG layer recycling has been 
observed and LdcA homologs exist for some species. However structure and the mode of 
action differ considerably from gram-negative bacteria.  
 
5. Summary 
   The structure of E. coli LdcA peptidase was solved in the native form as well as with 
an active site mutant replacing serine by alanine. This mutated structure showed an 
increased flexibility at the active site. Other bacterial species show similar conserved 
features of their LdcA active sites. A substrate-binding structure could not be obtained, 
indicating a strong specificity towards the substrate. The oligomeric form was confirmed 
to be a homodimer. 
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8. Glossary 
Cell-wall recycling: bacteria carefully fragment their cell wall avoiding lysis, but enabling 
insertion of new PG. Only a small part of the fragments are released, most are recovered 
and reused for several reasons: saving resources, suppression of host immune response, 
induction of β-lactamase production etc. 
Catalytic triad: Three amino acids, which are spatially close in the folded enzyme (not 
necessarily in sequence) that work together to hydrolyse a substrate. A nucleophile (serine 
in the case of LdcA) attacks the substrate. A histidine and acidic residue act to alter the 
pK of the serine, to make it a better nucleophile. 
Oligomeric form: is the quaternary structure of a protein consisting of more than one 
subunit, which self-assemble and are not covalently bond. Oligomerization has usually 
structural and functional advantages for proteins.  
